Treatment Approach

The Need for New Approaches to Treating Cancer

On December 23, 1971, President Richard Nixon signed the National Cancer Act, officially declaring America’s “war on cancer.” This watershed moment marked an unprecedented national commitment to combat what had become the country’s second leading cause of death. Nixon’s declaration promised to mobilize the nation’s resources against this formidable enemy, much like the Manhattan Project had done during World War II. The Act significantly increased federal funding for cancer research and established what would become a comprehensive national cancer program.

Fast-forward to today, while we have won significant battles—notably against certain blood cancers, early-stage breast cancer, and some childhood cancers—we certainly have not won the war. Cancer remains one of humanity’s most formidable adversaries, with metastatic disease in particular continuing to claim millions of lives annually. Contemporary cancer drugs, as research published in both 2004 and 2023 demonstrates (click here and click here), often have a limited impact on enhancing the quality of life or prolonging survival in metastatic cases. This persistence of cancer as a leading cause of death suggests that perhaps we need to take the warfare analogy more literally.

Strategic Warfare Against Cancer

Cancer cells are remarkably adaptable. When we attack them in one way, they often find alternate pathways to survive. Our protocol addresses critical gaps in contemporary cancer treatment. That’s why we employ a coordinated strategy that targets several cancer vulnerabilities at once. Think of it as surrounding the enemy from all sides rather than attacking from just one direction. Using a science-based combination of diet and lifestyle, targeted supplements, and carefully chosen repurposed/off-label prescription medications, our integrated multi-agent attack is designed to:

1. Cut off cancer’s fuel sources by reducing cancer’s access to key nutrients tumors need to grow and spread. Targeted compounds reverse abnormal cancer metabolism and disrupt energy pathways, while other agents create an energy crisis that starves cancer cells of their primary fuel sources.
2. Reduce cancer-promoting inflammation by targeting multiple inflammatory pathways that fuel tumor growth and spread. Key interventions reprogram immune cells from a cancer-supporting to cancer-fighting state, while other therapeutic components deactivate harmful inflammatory particles that perpetuate chronic inflammation.
3. Normalize the cancer microenvironment by correcting the acidic conditions surrounding tumors that make it easier for cancer to grow and spread. pH-modifying interventions neutralize tumor acidity to disrupt cancer cell metabolic adaptations and enhance immune cell function, while debris clearance mechanisms remove the inflammatory scaffolding that supports tumor growth.
4. Block survival mechanisms by preventing cancer cells from using autophagy and repair pathways that help them survive. Pathway inhibitors target critical cancer signaling networks, while oxidative agents overwhelm DNA repair mechanisms and trigger irreversible cell cycle arrest.
5. Kill cancer cells by subjecting them to overwhelming levels of oxidative stress. The coordinated generation of reactive oxygen species and reactive nitrogen species creates a powerful oxidative storm that damages cellular structures and DNA while selectively targeting cancer cells and sparing normal tissues.
6. Target cancer stem cells within tumors to prevent new growth or recurrence. This resilient subpopulation, responsible for tumor relapse and metastasis, is specifically targeted through pathway inhibition, anti-stemness properties, and membrane-disrupting effects that compromise their survival and regenerative capacity.
7. Help your immune system better recognize and fight cancer cells through multiple complementary mechanisms. Targeted interventions destroy cancer cells while exposing hidden tumor markers, immune modulators enhance natural killer cell activity and promote beneficial immune cell reprogramming, and metabolic cofactors provide essential support for sustained immune function.
8. Make standard therapies more effective by reducing the likelihood of cancer developing resistance and enhancing treatment sensitivity. The multi-agent approach helps prevent cancer cells from adapting to single interventions, while the microenvironment normalization and immune activation create optimal conditions for conventional therapies to work more effectively with reduced side effects.

Treatment Indications

Based on this comprehensive approach, our treatment may be particularly beneficial for:

1. Patients seeking to enhance the effectiveness and reduce the side effects of conventional cancer treatment
2. Patients who have not responded to or can no longer tolerate conventional treatment
3. Patients who do not qualify for a drug trial or failed to respond favorably to a trial drug
4. Patients who are in remission and wish to prevent cancer recurrence
5. Patients seeking to improve overall quality of life

Patient Care and Treatment Cost

Dr. Thomas’s practice is limited to no more than 50 patients at any given time—far fewer than the typical oncology caseload of 250 patients. This focused approach enables him to provide highly personalized care and conduct ongoing research to optimize treatment outcomes.

For cancers that are aggressive, late-stage, resistant to conventional treatment, or have recurred, repurposed/off-label prescription medications will be recommended. Before starting these medications, patients must have a physical examination in Dr. Thomas’s office. Bloodwork is be done throughout treatment to ensure safety, with medication dosages adjusted if needed. Tumor markers and imaging are obtained every three months to monitor treatment progress. Patients have monthly follow-up visits—either in person or via telemedicine—and have unrestricted email access to Dr. Thomas for continuous support.

For patients requiring ongoing care and close medical management by Dr. Thomas, there is a flat monthly fee. Treatment typically continues for 12-18 months until remission or disease stabilization is achieved. Please note that with the exception of bloodwork, integrative cancer treatment is not covered by health insurance or Medicare.